The Stage Before the Study.
Every contract research organization, data vendor, and freelance writer earns only after your study is decided. We built something different: the stage before. The Nexagen360 Research Readiness Assessment is a fixed-scope, fixed-price, fixed-timeline diagnostic that takes you from ‘we think we need a study’ to a decision-ready evidence brief — in 5 or 10 working days.
The most expensive study is the one you shouldn’t have run.
Evidence already existed, but nobody mapped it.
The research question was the wrong question.
Regulatory and data pathway stayed unclear until the study stalled.
Vendor costs arrived as surprises, not estimates.
The market will sell you a study. What it won’t give you is the answer to “should this study exist at all — and if so, in what shape?” That’s what we’re here for.
The Research Readiness Dossier
Eight components that take you from uncertainty to a decision-ready brief.
Evidence Landscape Map
Existing published and grey evidence, plus the genuine gaps.
GCC Disease Burden Snapshot
Why your question matters in this region — or doesn’t.
Research Question Refinement
Your question, pressure-tested.
Study Design Options
2–3 viable designs with trade-offs and data requirements.
GCC Regulatory & Data Pathway
Ethics and data-protection routes across UAE (EDE/DHA/DoH) and Saudi Arabia (SFDA).
Cost & Timeline Expectations
What the study should cost before you talk to vendors.
Feasibility Risk Register
The five risks most likely to sink the study.
Go / Refine / No-Go Recommendation
An honest verdict with your three next moves.
Why Our Verdict Is Worth Paying For
We don’t run studies, and we don’t grow our scope. Our fee stays the same whether your verdict is Go, Refine, or No-Go — our only stake is giving you the right answer.
And if the answer is Go, you’ll arrive at your vendor and CRO conversations as a sharper buyer: a defined question, realistic costs, and a clear regulatory pathway. A well-scoped brief makes every engagement that follows — yours and theirs — faster and smoother.
From Intake to Decision in 10 Days
Intake
15 questions, 20 minutes.
Full Desk Research
Evidence, regulatory, and burden mapping.
Physician Review + Validation Call
A 60-minute validation call.
Synthesis
We build your dossier.
Dossier Delivered + Debrief
Dossier delivered with a 60-minute debrief call.
Express delivers a condensed 6-page brief in 5 working days — desk research only, no calls.
Built for Decision-Makers
Pharmaceutical & healthcare companies entering the GCC or planning non-interventional research (NIS, RWE, HEOR, chart reviews).
Health authorities & hospital networks evaluating population-health or service-delivery research.
NGOs & community health programs needing evidence before committing budget.
Clear Scope. Clear Next Steps.
Two assessment packages are available — Express (condensed 6-page brief, 5 working days) and Full (complete dossier with validation and debrief calls, 10 working days). Assessments from $1,500. The full fee schedule is shared on your discovery call.
Straight Answers
No, deliberately. If your verdict is Go, the next step is a properly scoped design engagement. If No-Go, you just saved the cost of a study.